Awards for August 2013

Federal Awards – August 2013

August Awards

Abrams, John, NIH, Molecular and Genetic Control of Programmed Cell Death, $397,500; Abrams, John (P. Kurtz, Fellow), NIH, Non-canonical Gene Regulation through a Drosophila p53 enhancer, $29,597; Ahmad, Zahid, NIH, Molecular Basis of Autosomal Dominant Hypercholesterolemia in a Multiethnic Cohort, $155,250; Ahn, Chul, Univ. of North Texas/NIH, Social Vigilance and Atherosclerotic Risk, $37,643; Amatruda, James, Univ. of Minnesota/NIH, Molecular Epidemiology of Pediatric Germ Cell Tumors, $11,852; Barton, Theresa, HRSA, Ryan White Program; Dallas FAN, $1,043,119; Beutler, Bruce, NIH, Mutagenic Analysis of LPS Response, $784,775; Bezprozvanny, Ilya, NIH, Presenilins and Neuronal Calcium Dyshomeostasis, $459,113; Blount, Paul, NIH, Molecular Mechanisms of Mechanosensitive Channel Gating, $322,214; Brekken, Rolf, NIH, GPCR Regulation of Progenitor Cells in Pancreatic Cancer, $162,538; Buszczak, Michael, NIH, Decoding Stem Cell Chromatin Using Drosophila, $282,131; Buszczak, Michael (Fellow A. Carreira), NIH, Molecular Characterization of a Novel Function of the RNA-Binding Protein Rbfox, $29,699.

Castrillon, Diego, NIH, LKB1 Tumor Suppressor and Human Cancer, $732,590; Cheng, Edaire, NIH, Role of Periostin and Th2 Cytokines in Eosinophilic Esophagitis Fibrogenesis, $148,711; Chuang, David, Baylor Coll. of Medicine/NIH, Phenylbutyrate Therapy for Maple Syrup Urine Disease, $116,897; Collins, Robert, Natl. Marrow Donor Program/NIH, Blood and Marrow Transplant Clinical Trials Network, $126; Drazner, Mark, Duke Univ./NIH, Guiding Evidence Based Therapy Using Biomarker Intensified Treatment, $5,000; Elmquist, Joel, NIH, Interactions of Leptin and Central Serotonin Systems, $354,780; Farrar, John, NIH, Type 1 Interferon-Regulated T Helper Development - Supplement, $39,014; Farrar, John (S. Gonzales Van Horn, Fellow), NIH, Role of Type I Interferon in Allergic Asthma, $29,455; Gattineni, Jyothsna, NIH, Fibroblast Growth Factor 23 (FGF23) and Its Receptors, $145,195; Goodman, Joel, NIH, Simple Cellular Model for Lipodystrophy, $318,000; Hill, Joseph, NIH, STIM1: Master Regulator of Calcium Homeostasis in Cardiomyocytes, $378,420.

Hsieh, Jenny, NIH, Novel Mechanisms of Adult Neurogenesis in Physiological and Pathological Contexts, $129,168; Huang, Chou-Long, NIH, Membrane Trafficking of Renal Ion Transport Proteins in Potassium Homeostasis, $453,131; Huber, Kimberly, NIH, Mechanisms of mGluR Function and Dysfunction in Mouse Autism Models, $393,841; Igarashi, Peter, NIH, UT Southwestern O'Brien Kidney Research Core Center, $1,165,505; Johnson, Mark, EMMES Corp./NIH, Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial, $5,850; Johnson, Mark, Yale Univ./NIH, Insulin Resistance Intervention after Stroke (IRIS) Trial, $153; Knudsen, Erik, NIH, Action of RB Pathway in Breast Cancer Therapy - Supplement, $53,182; Kozlitina, Julia, NIH, Genetic Factors in Taste Perception and Tobacco Usage, $424,570; Kramer, Helmut, NIH, AMPylation, Novel Mechanism Regulating Visual Neurotransmission, $302,100; Kramer, Helmut, NIH, Proteomics of Neurotransmitter Recycling Domain in Glia of the Visual System, $188,614.

Lavery, Lawrence, New York Univ./AHRQ, Wound EMR to Decrease Limb Amputations in Persons with Diabetes, $26,000; Li, Bing, NIH, Mechanism for Chromatin Modification during Transcription Elongation, $288,612; Liu, Yi, NIH, Transcriptional and Posttranscriptional Regulation of Neurospora Circadian Clock, $326,050; Lu, Hanzhang, NIH, Vascular Physiology in Brain White Matter, $228,610; Luebke, Kevin, NIH, Ligands for Hairpin Precursor of MicroRNA Linked to Cancer and Heart Disease, $296,207; Luo, Xuelian, NIH, Activation Mechanism of the Tumor-Suppressing MST-LATS Kinase Cascade, $302,100; Maalouf, Naim, NIH, Pharmacological Therapy for Calcium Phosphate Urolithiasis, $191,794; Mahendroo, Mala, NIH, Defining Gene Expression Programs in Cervical Ripening: Roles for Non-Coding RNAs, $198,750; Mahony, Lynn, New England Research Inst./NIH, Pediatric Heart Disease Research Protocol Chair, $69,371; Malloy, Craig, NIH, Southwestern NMR Center for In Vivo Metabolism, $1,048,290.

Mangelsdorf, David, Univ. of Pennsylvania/NIH, Mechanisms and Treatment of Chronic, Latent Human Strongyloidiasis, $7,950; Martinez, Elisabeth, NIH, Characterization of Biological Activities of Novel Epigenetic Modulators - Supplement, $86,389; Mendell, Joshua, NIH, c-Myc-regulated microRNAs in Normal and Pathologic Cellular Physiology, $293,037; Miller, David, Gynecologic Oncology Group/NIH, Corpus Committee Chair Agreement, $7,765; Mitchell, Mack, Cleveland Clinic Fndn./NIH, Novel Therapies in Alcoholic Hepatitis, $32,970; Mohan, Chandra, NIH, Foreboding Lupus Nephritis in Minority Women, $422,816; Nedzi, Lucien, American College of Radiology/NIH, Radiation Therapy Oncology Group, $9,400; Olson, Eric, NIH, Deciphering Regulatory Circuit for Myocardial Metabolism and Energy Homeostasis - Supplement, $30,078; Otwinowski, Zbyszek, Northwestern Univ./NIH, Center for Structural Genomics of Infectious Diseases, $9,619; Pandita, Tej, NIH, Chromatin Modifying Factors Control Radiation Response and Genomic Stability, $320,027.

Patel, Vishal, NIH, Role of microRNA in Kidney Development and Pathogenesis of PKD, $145,555; Powell, Craig, NIH, Novel Genetic Models of Autism, $320,643; Powell, Craig, NIH, Novel Genetic Models of Autism - Supplement, $94,685; Raskin, Philip, Tufts Univ./NIH, Vitamin D and Type 2 Diabetes (D2d Study), $313,249; Raskin, Philip, George Washington Univ./NIH, Glycemia Reduction Approaches for Diabetes: Comparative Effectiveness (GRADE), $264,053; Rothenfluh, Adrian (S. Ojelade, Fellow), NIH, Role of Icarus in Ethanol-Induced Behaviors, $29,516; Sanchez, Pablo, RTI Intl./NIH, NICHD Neonatal Research Network Capitation Funding, $7,877; Sawant, Amit, NIH, Personalized Motion Management for truly 4D Lung Stereotactic Body Radiotherapy, $544,497; Schaffer, Joseph, RTI Intl./NIH, NICHD Pelvic Floor Disorders Network - Capitation Funding, $350; Schiller, Joan, NIH, Physician Scientist Oncology Training Program, $156,120; Self, David, Mount Sinai School of Medicine/NIH, Molecular Neurobiology of Drug Addiction, Pj 3, $147,870.

Shaul, Philip, NIH, Fc gramma RIIB and Inflammation-Related Vascular Disease, $356,262; Shay, Jerry, NIH, Cancer Biology Training Grant, $363,359; Sherry, Dean, NIH, Imaging Beta Cell Function in Vivo with Zinc Responsive MRI Contrast Agent, $333,722; Shiloh, Michael, NIH, Carbon Monoxide Resistance in Mycobacterium Tuberculosis Pathogenesis, $373,650; Singal, Amit, Kaiser Fndn. Research Inst./NIH, CRN4: Cancer Research Resources & Collaboration in Integrated Health Care Systems, $7,064; Skinner, Celette, NIH, Parkland-UT Southwestern PROSPR Center: Colon Cancer Screening in Safety Net, $1,129,880; Slone, Tamra, Children’s Hosp. and Health System/NIH, COG CHOP Cancer Control Grant, $3,430; Smith, Dean, NIH, Genetic Analysis of Olfaction, $303,732; Snell, William, NIH, Gamete Membrane Adhesion and Fusion during Fertilization, $268,511; Sun, Xiankai, NIH, Noninvasive Assessment of Pancreatic Beta-Cell Mass (MPI), $336,532; Takarae, Yukari, NIH, Electrophysiological Correlates of Cognitive Control in Autism, $41,006.

Timaran, Carlos, Univ. of Medicine & Dentistry of New Jersey/NIH, Carotid Revascularization Endarterectomy vs. Stent Trial (CREST), $1,800; Trivedi, Madhukar, NIH, Clinical Trial Network: North Texas Node - Infrastructure, $768,586; Tu, Benjamin, NIH, Metabolic Signals Driving Cell Growth and Proliferation, $303,801; Udugamasooriya, Damith, NIH, Direct Identification of Ready-to-Use Peptoid-DOTA Theranostic Systems, $187,421; Wan, Yihong, U.S. Dept. of Defense, MicroRNA as Novel Suppressor of Osteoclastogenesis and Bone Metastasis of Breast Cancer, $198,750; Wang, Richard, NIH, Elucidating Role of Akt and Keratins in Autophagy and Tumorigenesis, $134,953; Wang, Serena, Jaeb Ctr. for Health Research/NIH, Pediatric Eye Disease Investigator Group: Amblyopia Treatment Study, $636; Witkiewicz, Agnieszka, NIH, Impact of ErbB2 and RB Pathways on DCIS Progression and Treatment (Year 2), $322,198; Witkiewicz, Agnieszka, NIH, Impact of ErbB2 and RB Pathways on DCIS Progression and Treatment (Year 3), $310,118.

Wolf, Steven, UT Medical Branch at Galveston/U.S. Dept. of Defense, Vitamin E Supplementation in Burn Patients, $49,715; Wolf, Steven, Geneva Fndn./U.S. Dept. of Defense, Phases of Illness Paradigm (POIP), $46,784; Word, Ann, NIH, Elastic Fiber Homeostasis in the Vaginal Wall (MPI), $336,508; Zhang, Song, NIH, Using VA Registry Data to Estimate Age-Related Risk Trajectories for HIV Patients, $75,128; Zhang, Xuewu, NIH, Regulation Mechanisms for GTPase Activating Protein Domain of Plexins, $296,979; Zigman, Jeffrey (A. Uchida, Fellow), NIH, Mechanisms for the Ghrelin Response to Caloric Restriction and Gastric Bypass, $49,214.

Nonfederal Awards – August 2013

Bradley-Guidry, Carolyn, Susan G. Komen for the Cure, Screening Our Sisters, $70,000; Cannon, Stephen, Muscular Dystrophy Assn., Disease Pathogenesis and Modification in Mouse Model of HypoPP, $132,749; Frohman, Elliot, Cleveland Clinic Fndn./Natl. Multiple Sclerosis Soc., Validation Study of Diffusion Tensor Imaging as Physiologically Relevant Biomarker of Brain Tissue Integrity, $50,000; Frohman, Elliot (S. Beh, Fellow), Biogen Idec Inc., Biogen Idec Multiple Sclerosis Clinical Fellowship Program in Multiple Sclerosis and Neuro-ophthalmology, $45,000; Hiesinger, Peter, Muscular Dystrophy Assn., Drosophila Model for Charcot-Marie-Tooth 2B Disease, $55,000; Hooper, Lora (M. Derebe, Fellow), Burroughs Wellcome Fund, Retinol Binding Functions of Serum Amyloid A Proteins, $20,000; Huber, Kimberly, Simons Fndn., Mechanisms of Synapse Elimination by Autism-Linked Genes, $180,233; Jain, Raksha, Cystic Fibrosis Fndn., Cystic Fibrosis Foundation Care Center Grant, $88,650.

Liu, Ning, American Heart Assn. SW, Cardiac Repair and Regeneration by Twist-1 and Twist-2, $70,000; Liu, Xin, Rita Allen Fndn., Structural and Mechanistic Studies of Promoter-Terminator Gene Looping, $100,000; McCavit, Timothy (M. Mathias, Fellow), American Society of Hematology, Extended Survival Analysis of the Dallas Newborn Cohort, $5,000; Mineo, Chieko, American Heart Assn. SW, Novel Function of FcgammaRIIB as Mediator of Obesity-induced Insulin Resistance, $70,000; Skapek, Stephen, St. Baldrick’s Fndn., Molecular Targeting in Non-Rhabdomyosarcoma Soft Tissue Sarcoma, $174,662; Thomas, Philip, Cystic Fibrosis Fndn., Development of Methods and Reagents for Assessing CFTR Folding, $87,330; Zaki, Hasan, Crohn’s & Colitis Fndn., Regulation of adaptive response by NLRP12 During Inflammation and Cancer, $90,000; Zigman, Jeffrey, Univ. of Copenhagen/Novo Nordisk, Enteroendocrine Brain Interactions Controlling Metabolism, Motivation and Mood, $124,886.

Industry Sponsored Awards, dollar amounts not available – August 2013

Amin, Alpesh, Integrated Diagnostic Evaluation in Non-Therapy Devices For the Study of Heart Failure - IDENTIFY HF; Brekken, Rolf, Vascular Targeting Agents for Treatment of Diseases; Davis, Kathryn, Lipoaspirate Stem Cell Viability: Hydrosolve vs. Coleman; Davis, Kathryn, Keloid Collection Study; Knudsen, Erik, Determinants of response to PD-0332991 in tumor specimen; Olson, Eric, Delivery Means of Anti-MiRs and MiR Mimics to Heart in Animal Models; Story, Michael, Preclinical Evaluation of GC4419.